1. Home
  2. TKNO vs NNOX Comparison

TKNO vs NNOX Comparison

Compare TKNO & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$4.58

Market Cap

236.6M

Sector

Health Care

ML Signal

HOLD

Logo NANO-X IMAGING LTD

NNOX

NANO-X IMAGING LTD

HOLD

Current Price

$3.73

Market Cap

253.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKNO
NNOX
Founded
1996
2011
Country
United States
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.6M
253.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TKNO
NNOX
Price
$4.58
$3.73
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
150.1K
2.6M
Earning Date
11-06-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,801,000.00
$12,302,000.00
Revenue This Year
$8.79
$20.19
Revenue Next Year
$10.52
$137.69
P/E Ratio
N/A
N/A
Revenue Growth
9.50
15.19
52 Week Low
$3.94
$2.78
52 Week High
$10.37
$11.00

Technical Indicators

Market Signals
Indicator
TKNO
NNOX
Relative Strength Index (RSI) 45.85 49.38
Support Level $4.53 $3.62
Resistance Level $4.87 $3.88
Average True Range (ATR) 0.30 0.37
MACD 0.05 -0.00
Stochastic Oscillator 59.72 45.07

Price Performance

Historical Comparison
TKNO
NNOX

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.

Share on Social Networks: